Please share...
The U.S. Food and Drug Administration approved Blueprint Medicines Corp’s oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday.
FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month
January 10, 2020By
